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Abstract
Cardiac hypertrophy that accompanies hypertension seems to be a
phenomenon of multifactorial origin whose development does not
seem to depend on an increased pressure load alone, but also on local
growth factors and cardioadrenergic activity. The aim of the present
study was to determine if sympathetic renal denervation and its effects
on arterial pressure level can prevent cardiac hypertrophy and if it can
also delay the onset and attenuate the severity of deoxycorticosterone
acetate (DOCA)-salt hypertension. DOCA-salt treatment was initiated
in rats seven days after uninephrectomy and contralateral renal dener-
vation or sham renal denervation. DOCA (15 mg/kg, sc) or vehicle
(soybean oil, 0.25 ml per animal) was administered twice a week for
two weeks. Rats treated with DOCA or vehicle (control) were provid-
ed drinking water containing 1% NaCl and 0.03% KCl. At the end of
the treatment period, mean arterial pressure (MAP) and heart rate
measurements were made in conscious animals. Under ether anesthe-
sia, the heart was removed and the right and left ventricles (including
the septum) were separated and weighed. DOCA-salt treatment pro-
duced a significant increase in left ventricular weight/body weight
(LVW/BW) ratio (2.44 ± 0.09 mg/g) and right ventricular weight/body
weight (RVW/BW) ratio (0.53 ± 0.01 mg/g) compared to control (1.92
± 0.04 and 0.48 ± 0.01 mg/g, respectively) rats. MAP was significantly
higher (39%) in DOCA-salt rats. Renal denervation prevented (P>0.05)
the development of hypertension in DOCA-salt rats but did not
prevent the increase in LVW/BW (2.27 ± 0.03 mg/g) and RVW/BW
(0.52 ± 0.01 mg/g). We have shown that the increase in arterial
pressure level is not responsible for cardiac hypertrophy, which may
be more related to other events associated with DOCA-salt hyperten-
sion, such as an increase in cardiac sympathetic activity.
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Left ventricular hypertrophy (LVH) that
accompanies arterial hypertension is consid-
ered to be an occurrence of multifactorial
origin involving neurohormonal mechanisms.
The development of LVH does not seem to
depend only on an increased pressure load to
the heart, but also on local growth factors
and cardioadrenergic activity (1). Although
local renin-angiotensin systems may influ-
ence cardiac myocyte growth and therefore
contribute to the development of LVH (2,3),
a body of evidence has accumulated show-
ing that sympathetic activity may be effec-
tive in inducing the cardiac hypertrophy as-
588
Braz J Med Biol Res 31(4) 1998
A.M. Cabral et al.
sociated with various forms of arterial hy-
pertension. The role played by the sympa-
thetic nervous system in the development of
cardiac hypertrophy is well understood (4,5),
but not the role played by high blood pres-
sure. For example, hyperactivity of the sym-
pathetic nervous system induced by sinoaortic
denervation (6,7) even in the acute phase is
capable of eliciting LVH in male rats (8).
Furthermore, chronic administration of the
sympathomimetic drug isoproterenol pro-
duces cardiac hypertrophy in rats (9-12).
However, little is known about the influence
of renal sympathetic nerve activity on LVH.
It is known that chronic sympathetic renal
nerve denervation delays the onset and at-
tenuates the severity of deoxycorticosterone
acetate (DOCA)-salt hypertension (13). Thus,
the objective of the present study was to
determine whether sympathetic renal dener-
vation and its effects on the pressure load
can prevent cardiac hypertrophy and whether
it can also delay the onset and attenuate the
severity of DOCA-salt hypertension.
Male adult Wistar rats (240-260 g) were
subjected to unilateral nephrectomy (right
kidney) under anesthesia with ketamine (30
mg/kg, im) in combination with xylazine (3
mg/kg, im). During the same surgical proce-
dure the left kidney was subjected to sympa-
thetic denervation or a sham operation. Re-
nal denervation was performed via a lateral
flank incision. The renal artery and vein
were stripped of the adventitia, the renal
nerve bundles were cut and the vessels were
coated with a solution of 10% phenol in
absolute ethanol as previously described (14).
DOCA-salt treatment was initiated seven
days later. DOCA (Sigma Chemical Co., St.
Louis, MO, 15 mg/kg, sc) or vehicle (soy-
bean oil, 0.25 ml per animal) was adminis-
tered twice a week for 15 days. Rats were
housed in semi-metabolic cages, treated with
DOCA or vehicle (control) and provided
with drinking water containing 1% NaCl and
0.03% KCl. The control group included nine
uninephrectomized and sham-denervated
rats. DOCA-salt groups included 11 rats
uninephrectomized and sham-denervated
(DOCA-salt) only, and 9 rats submitted to
uninephrectomy plus contralateral renal de-
nervation (DOCA-salt-denervated) rats.
At the end of the treatment period, rats
were anesthetized with ether and instru-
mented with catheters (PE-50) in the left
femoral artery and vein. The polyethylene
catheter was tunneled to exit at the back of
the neck, flushed and filled with 40 U/ml
heparinized saline. Six hours later, mean
arterial pressure (MAP) and heart rate (HR)
measurements were made in conscious ani-
mals using a pressure transducer (P23XL,
Statham, Valley View, OH) coupled to a
polygraph (RS 3400, Gould Instruments Sys-
tems, Valley View, OH). The animals in
their home cages were allowed to acclima-
tize to the laboratory for 1 h while they were
being connected for measurements. After
the hemodynamic variables were recorded,
the animals were anesthetized with ether, the
heart was removed and the right and left
ventricles (including the septum) were sepa-
rated and weighed. Statistical analysis of
data was performed by two-way analysis of
variance followed by a post-hoc protected
Tukey’s test. All experiments were conducted
in conformity with international guidelines
for biomedical research involving animals.
Fifteen days of DOCA-salt treatment re-
sulted in a significant increase in left ventric-
ular weight/body weight (LVW/BW) ratio
(2.44 ± 0.09 mg/g) and right ventricular
weight/body weight (RVW/BW) ratio (0.53
± 0.01 mg/g) compared to age-matched con-
trol (1.92 ± 0.04 and 0.48 ± 0.01 mg/g,
respectively) rats as illustrated in Figure 1.
As shown in Table 1, MAP was significantly
higher (39%) in DOCA-salt rats. Renal de-
nervation significantly prevented the devel-
opment and high level of hypertension in the
DOCA-salt rats. In contrast, DOCA-salt ad-
ministration still caused a significant increase
in LVW/BW ratio (2.27 ± 0.03 mg/g) and
RVW/BW ratio (0.52 ± 0.01 mg/g) in renal-
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denervated rats compared to age-matched
controls (Figure 1), even though the MAP
did not reach the hypertension level observed
in the DOCA-salt group. There was no sig-
nificant difference in daily saline intake be-
tween the DOCA-salt (50 ± 5 ml) and DOCA-
salt-denervated (47 ± 6 ml) rats, whose val-
ues were significantly higher than observed
in the control (29 ± 5 ml) group.
The present data show that sympathetic
renal denervation does not prevent the de-
velopment of DOCA-salt-induced left and
right ventricular hypertrophy despite pre-
venting the high level of hypertension caused
by DOCA-salt rats. The long-term control of
arterial pressure is thought to be regulated by
the renal control of fluid and electrolyte
balance (15), and evidence has accumulated
suggesting that renal sodium excretion is
impaired, at least in part, via a renal sympa-
thetic nerve action (16). Renal denervation
has been documented to delay the onset and
attenuate the severity of some forms of hy-
pertension of different pathogenesis (13,17).
The significance of the present results is that
they support an important role for renal sym-
pathetic nerve activity in hypertension in-
duced by DOCA and salt overload, as shown
previously (18). It appears that DOCA-salt
treatment increases plasma sodium content
by increasing renal tubular reabsorption of
sodium via a renal nerve pathway (19). So-
dium retention is facilitated by increases in
renal sympathetic nervous activity by ac-
tions due to a direct tubular effect (16), and
renal vasoconstriction (20). The present re-
sults clearly demonstrate that the blunted
renal sympathetic activity can interfere with
blood pressure only, with no influence on
cardiac hypertrophy, corroborating the con-
cept that factors other than pressure over-
load may influence the development of car-
diac mass. In this situation, the DOCA-salt
treatment increases the sympathetic activity
to the heart, which in turn may elicit cardiac
hypertrophy. In this regard, changes in nor-
epinephrine content related to blood pres-
sure have been documented in cardiac tis-
sues from DOCA-salt rats as a consequence
of augmented norepinephrine turnover in-
duced by a chronic general increase in sym-
pathetic activity (21). In addition, studies
performed by Cabral et al. (8) showed a
rapid onset cardiac hypertrophy in sinoaortic
baroreceptor denervated rats. It is well known
that sinoaortic denervation elicits sympa-
thetic hyperactivity (22).
We have shown that an increase in arteri-
al pressure level is not responsible for car-
diac hypertrophy, which may be more re-
lated to other mechanisms paralleling DOCA-
salt hypertension, such as a possible increase
in cardiac sympathetic activity.
Figure 1 - Effect of renal dener-
vation (DSD, N = 9) on ratios of
left and right ventricular weight
(wt) of deoxycorticosterone-salt
(DS, N = 11) hypertensive and
time-match control (CON, N = 9)
rats. Values are reported as the
mean ± SEM. *P<0.05 and
**P<0.01 compared to control
group values.
Table 1 - Influence of renal denervation on cardiovascular parameters of
uninephrectomized Wistar rats with or without DOCA-salt treatment.
The measurements were performed after 15 days of DOCA-salt treatment. The
groups of rats studied were: sham-denervated with vehicle treatment (control, N = 9),
sham-denervated with DOCA-salt treatment (DOCA-salt, N = 11) and denervated with
DOCA-salt treatment (DOCA-salt denervation, N = 9) groups. Values are reported as
the mean ± SEM. * P<0.05 and **P<0.01 compared to control group values; +P<0.05
and ++P<0.01 compared to DOCA-salt group values
Measurements Groups
Control DOCA-salt DOCA-salt denervation
MAP (mmHg) 113 ± 4.0 157 ± 5.5** 122 ± 4.5++
HR (beats/min) 347 ± 6.0 365 ± 14.5 359 ± 13.5
Body weight (g) 286 ± 11 275 ± 3.0 271 ± 6.0
Left ventricular weight (mg) 551 ± 13.5 670 ± 21** 615 ± 11*+
Right ventricular weight (mg) 137 ± 3.0 147 ± 3.0* 142 ± 4.5
Le
ft 
ve
nt
ric
ul
ar
 w
t (
mg
)/b
od
y w
t (
g) 3
2
1
0
R
ig
ht
 v
en
tri
cu
la
r w
t (
mg
)/b
od
y w
t (
g)
0.60
0.40
0.20
0.00
* *
* *
*
* *
CON DS DSD
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
12345
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123456
123
123
590
Braz J Med Biol Res 31(4) 1998
A.M. Cabral et al.
References
1. Seen S & Tarazi RC (1986). Cardiovascular
hypertrophy in spontaneously hyperten-
sive rats. Journal of Hypertension, 4: 123-
126.
2. Dzau VJ (1988). Cardiac renin-angiotensin
system: molecular and functional aspects.
American Journal of Medicine, 8 (Suppl
3A): 22-26.
3. Bissoli NS, Moyses MR, Vasquez EC &
Cabral AM (1991). Captopril prevents ven-
tricular hypertrophy in sinoaortic dener-
vated rats. Brazilian Journal of Medical
and Biological Research, 24: 191-194.
4. Caldarera CM, Giorgi PP & Casti A (1970).
The effect of noradrenaline on polyamine
and RNA synthesis in the chick embryo.
Journal of Endocrinology, 46: 115-116.
5. Ostman-Smith I (1981). Cardiac sympa-
thetic nerves as the final common path-
way in the induction of adaptative cardiac
hypertrophy. Clinical Science, 61: 265-
272.
6. Saavedra JM & Krieger EM (1987). Early
increase in adrenomedullary catechola-
mine synthesis in sinoaortic denervated
rats. Journal of the Autonomic Nervous
System, 18: 181-183.
7. Irigoyen MC, Cestari IA, Moreira ED,
Oshiro MS & Krieger EM (1988). Meas-
urements of renal sympathetic nerve ac-
tivity in conscious sinoaortic denervated
rats. Brazilian Journal of Medical and Bio-
logical Research, 21: 869-872.
8. Cabral AM, Vasquez EC, Mill JG & Futuro-
Neto HA (1983). Ventricular hypertrophy
in sinoaortic devervated rats. Brazilian
Journal of Medical and Biological Re-
search, 16: 353-356.
9. Taylor PB & Tang Q (1984). Development
of isoproterenol-induced cardiac hypertro-
phy. Canadian Journal of Physiology and
Pharmacology, 62: 384-389.
10. Yamori Y, Kihara M, Ikeda K, Ooshima A &
Tarazi RC (1980). Cardiac hypertrophy in
early hypertension. Japonese Heart Jour-
nal, 21: 566-570.
11. Johnson MD, Grignolo A, Kuhn CM &
Schanberg SM (1983). Hypertension and
cardiovascular hypertrophy during chronic
catecholamine infusion in rats. Life Sci-
ences, 33: 169-180.
12. Newling RP, Fletcher PJ, Contis M &
Shaw J (1989). Noradrenaline and cardiac
hypertrophy in the rat: changes in mor-
phology, blood pressure and ventricular
performance. Journal of Hypertension, 7:
561-567.
13. Katholi RE, Naftilan AJ & Oparil S (1980).
Importance of renal sympathetic tone in
the development of DOCA-salt hyperten-
sion in the rat. Hypertension, 2: 266-273.
14. DiBona GF & Sawin L (1983). Renal
nerves in renal adaptation to dietary so-
dium restriction. American Journal Physi-
ology, 245: F322-F328.
15. Guyton AC (1990). Long-term arterial
blood pressure control: an analysis from
animal experiments and computer and
graphic models. American Journal Physi-
ology, 259: R865-R877.
16. DiBona GF, Zambraski EJ, Aguilera AJ &
Kaloyanides GJ (1977). Neurogenic con-
trol of renal tubular sodium reabsorption
in the dog. Circulation Research, 40: I-
127-I-130.
17. Matsuoka H, Nishida H, Nomura G, Van
Vliet BN & Toshima H (1994). Hyperten-
sion induced by nitric oxide synthesis in-
hibition is renal nerve dependent. Hyper-
tension, 23 (Part 2): 971-975.
18. Musso MN, Vasquez EC, Carvalhinho FB,
Bissoli NS & Cabral AM (1990). Chlorthali-
done alters the vascular reactivity of Doc-
salt hypertensive rats to norepinephrine.
Brazilian Journal of Medical and Biological
Research, 23: 999-1003.
19. Cabral AM, Musso MN, Bissoli NS,
Carvalhinho FB & Vasquez EC (1992).
Chlorthalidone reduces vascular hyperre-
sponsiveness in Doca-salt hypertensive
rats. Clinical and Experimental Hyperten-
sion. Theory and Practice, A14: 667-683.
20. Schrier RW (1974). Effects of adrenergic
nervous system and catecholamines on
systemic and renal hemodynamics, so-
dium and water excretion and renin se-
cretion. Kidney International, 6: 291-306.
21. Doyle AE (1968). Endogenous-catechola-
mines content of cardiac muscle in so-
dium-loaded and sodium depleted rats.
Lancet, 1: 1399-1400.
22. Vasquez EC & Krieger EM (1982). De-
creased chronotropic responses to adre-
nergic stimulation following sinoaortic de-
nervation in the rat. Brazilian Journal of
Medical and Biological Research, 15: 377-
387.
